EP3125885
COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.4.2015EP published:
30.6.2021EP application number:
15715805.6
EPO information:
European Patent Register
Max expiry date:
1.4.2035
Title:
COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER
Timeline
Today
2.4.2015EP application
30.6.2021EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
CROSS, Darren Anthony EdwardAddress:
Cambridge Cambridgeshire CB4 0WG, GB
Name:
EBERLEIN, Catherine AnneAddress:
Macclesfield Cheshire SK10 4TG, GB
Priority
Number:
201461975088 PDate:
4.4.2014Country:
US
Number:
201462013573 PDate:
18.6.2014Country:
US
Classification
Categories:
A61K 31/4184, A61K 31/506, A61P 35/00, A61K 31/5377